期刊文献+

脂蛋白磷脂酶A2基因V279F和A379V多态性与老年冠心病的关系 被引量:1

Association of V279F, A379V polymorphism in lipoprotein-associated phospholipase A2 gene with elderly coronary heart disease
下载PDF
导出
摘要 目的探讨脂蛋白磷脂酶A2基因V279F和A379V多态性位点与老年冠心病(CHD)患者遗传易感性的关系。方法纳入227例CHD患者和101例正常对照者,应用DNA测序仪测脂蛋白磷脂酶A2基因V279F和A379V的基因多态性。结果 (1)CHD组V279F和A379V的基因型和等位基因频率与对照组无明显差异;(2)心肌梗死组V279F和A379V的基因型等位基因频率与非心肌梗死组亦无明显差异。(3)logistic回归分析未能发现V279F和A379V变异是CHD的危险因素。结论脂蛋白磷脂酶A2基因V279F和A379V多态性与中国汉族老年人口CHD无明显相关性。 Objective To investigate the association of V279F and A379V point mutation of lipoprotein-associated phospholipase A2 (Lp-PLA2) with coronary heart disease (CHD) in the elderly patients. Methods 227 patients with CHD and 101 controls were genotyped by DNA sequencing instrument. Results There were no significant differences between CHD group and control group in the frequencies of V279F and A379V genotypes and allele, but the frequency of the 379V allele was significantly higher in the patients with myocardial infarction(MI) than that in the patients without MI (P<0.05). Binary logistic regression analysis demonstrated that polymorphism of V279F and A379V was not an independent risk factor for CHD. Conclusions The V279F and A379V polymorphism of Lp-PLA2 gene has no significant correlation with CHD in the elderly patients, while 379V allele may increase the risk of MI in the Chinese Han elderly population.
出处 《实用老年医学》 CAS 2013年第4期321-324,共4页 Practical Geriatrics
基金 江苏省自然科学基金资助项目(BK2009450) 江苏省社会发展基金资助项目(BE2011804)
关键词 脂蛋白磷脂酶A2 基因 多态性 冠心病 lipoprotein-associated phospholipase A2 gene polymorphism coronary heart disease
  • 相关文献

参考文献11

  • 1Liping Hou,Shufeng Chen,Hongjiang Yu,Xiangfeng Lu,Jianhong Chen,Laiyuan Wang,Jianfeng Huang,Zhongjie Fan,Dongfeng Gu.Associations of PLA2G7 gene polymorphisms with plasma lipoprotein-associated phospholipase A2 activity and coronary heart disease in a Chinese Han population: the Beijing atherosclerosis study[J].Human Genetics.2009(1)
  • 2Li L,Qi L,Lv N,et al.Association between lipoprotein-associated phospholipase A2 gene polymorphism and coronary artery disease in the Chinese Han population[].Annals of Human Genetics.2011
  • 3Yamada Y,Yoshida H,Ichihara S,et al.Correlations between plasma platelet-activating factor acetylhydrolase (PAF-AH)activity and PAF-AH genotype, age, and atherosclerosis in a Japanese population[].Atherosclerosis.2000
  • 4Kruse S,Mao X Q,Heinzmann A,et al.The Ile198Thr and Ala379Val variants of plasmatic PAF-acetylhydrolase impair catalytical activities and are associated with atopy and asthma[].The American Journal of Human Genetics.2000
  • 5Madjid M,Willerson JT.Inflammatory markers in coronary heart disease[].British Medical Bulletin.2011
  • 6Ninio E,Tregouet D,Carrier JL,et al.Platelet-activating factor-acetyl-hydrolase and PAF-receptor gene haplotypes in relation to future ca-rdiovascular event in patients with coronary artery disease[].Human Molecul Gene.2004
  • 7Liu PY,Li YH,Wu HL, et al.Platelet-activating factor-acetylhydrolase A379V (exon 11) gene polymorphism is an independent and functional risk factor for premature myocardial infarction[].Journal of Thrombosis and Haemostasis.2006
  • 8P Libby.Inflammation in atherosclerosis[].Arteriosclerosis and Thrombosis.2012
  • 9Rosenson RS,Stafforini DM.Modulation of oxidativestress,inflammation,and atherosclerosis by lipoprotein-associated phospholipase A2[].Journal of Lipid Research.2012
  • 10Sutton BS,Crosslin DR,Shah SH,et al.Comprehensive genetic analysis of the platelet activating factor aeetylhydrolase (PLA2G7) gene and cardiovascular disease in case-control and family datasets[].Human Molecular Genetics.2008

同被引文献38

  • 1朱启伟,高鹏,张今尧,曹瑞华,白永怿,骆雷鸣.80岁以上老年冠心病患者心肌损伤程度与血浆NT-proBNP水平关系的临床研究[J].实用老年医学,2013,27(5):427-430. 被引量:8
  • 2Garlanda C, Dinarello CA, Mantovani A. The interleukin-1 family: back to the future [ J ]. Im- munity, 2013,39(6) : 1003-1018.
  • 3Sims JE, Smith DE. The IL-1 family : regulators of immunity [ J ]. Nat Rev Immunol, 2010, 10 (2) : 89-102.
  • 4Duewell P, Kono H, Rayner K J, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals [ J ]. Nature, 2010, 464 ( 7293 ): 1357-1361.
  • 5van de Veerdonk FL, Netea MG. New insights in the immunobiology of IL-1 family members [ J]. Front Im-munol, 2013,4:167.
  • 6Rider P, Carmi Y, Guttman O, et al. IL-lalpha and IL-lbeta recruit different myeloid cells and promote different stages of sterile inflammation [ J ]. J Immunol, 2011, 187(9) :4835-4843.
  • 7Berda-Haddad Y, Robert S, Salers P, et al. Sterile inflammation of en- dothelial cell-derived apoptotic bodies is mediated by interleukin- lalpha EJ]- Proc Nat Acad Sci U S A, 2011,108(51 ) :20684-20689.
  • 8Fearon WF, Fearon DT. Inflammation and cardiovascular dis- ease: role of the interleukin-1 receptor antagonist [ J]. Circulation, 2008,117 (20) : 2577-2579.
  • 9Waehre T, Yndestad A, Smith C, et al. Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors [ J ]. Circulation, 2004, 109 ( 16 ) : 1966-1972.
  • 10Ridker PM, flammatory Luscher TF therapies for cardiovascular disease [ J ]. Eur Heart J, 2014,35(27) : 1782-1791.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部